Patent · US Active

Methods and DNA constructs for autoregulating transgene silencing

US9222100B2 · kind B2 · utility

0Cited by
10References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 24, 2010
Grant dateDec 29, 2015
Priority date
Expiry dateAug 24, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/8286
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This invention provides a method to autoregulate expression of a transgene susceptible to sRNA silencing by concomitantly transcribing RNA from DNA of a transgene and RNA from DNA from at least one sRNA silencing pathway gene. An aspect of the invention provides use of a recombinant DNA construct that includes DNA of a transgene and DNA of an sRNA silencing regulator. Also disclosed are transgenic cells and organisms having in their genome a recombinant DNA construct that includes DNA of a transgene and DNA of an sRNA silencing regulator.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.